The psychedelic ingredient in “magic mushrooms” continues to reveal therapeutic powers, according to a new study.
In a significant randomized controlled trial, researchers at 11 sites across the US compared a single dose of psilocybin with a placebo concluding that the chemical could have positive effects on people suffering from depression.
The study, published in the Journal of the American Medical Association (JAMA), indicates that psilocybin (the ingredient that makes you trip when consuming mushrooms with your friends) may offer a faster and more durable solution than existing antidepressants for treating major depressive disorder (MDD), with effects noticeable within a week.
“Psilocybin treatment was associated with a clinically significant sustained reduction in depressive symptoms and functional disability, without serious adverse events,” the study concludes. “These findings add to increasing evidence that psilocybin—when administered with psychological support—may hold promise as a novel intervention for MDD.”
Magic mushrooms, once a staple of ‘60s counterculture, are
Go to Source to See Full Article
Author: Jose Antonio Lanz
Tip BTC Newswire with Cryptocurrency